175 related articles for article (PubMed ID: 1912665)
1. The management of haemoglobinopathies.
Davies SC; Wonke B
Baillieres Clin Haematol; 1991 Apr; 4(2):361-89. PubMed ID: 1912665
[No Abstract] [Full Text] [Related]
2. Iron chelating therapy in thalassemia: current problems.
Russo G
Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
[No Abstract] [Full Text] [Related]
3. The treatment of Cooley's anemia.
Nathan DG
Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
[No Abstract] [Full Text] [Related]
4. Outcome of thalassemia treated with conventional therapy.
Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
[No Abstract] [Full Text] [Related]
5. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
6. Growth and sexual maturation in thalassemia major.
Borgna-Pignatti C; De Stefano P; Zonta L; Vullo C; De Sanctis V; Melevendi C; Naselli A; Masera G; Terzoli S; Gabutti V
J Pediatr; 1985 Jan; 106(1):150-5. PubMed ID: 3965675
[TBL] [Abstract][Full Text] [Related]
7. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
Kattamis CA; Kattamis AC
Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
[No Abstract] [Full Text] [Related]
8. Endocrine function in thalassemia major.
Canale VC; Steinherz P; New M; Erlandson M
Ann N Y Acad Sci; 1974; 232(0):333-45. PubMed ID: 4369990
[No Abstract] [Full Text] [Related]
9. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major].
Pomarède R; Girot R; Constant S; Rappaport R
Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sickle cell beta o-thalassemia and sickle cell beta +-thalassemia in black populations.
Serjeant GR; Serjeant BE
Birth Defects Orig Artic Ser; 1982; 18(7):223-9. PubMed ID: 7159733
[No Abstract] [Full Text] [Related]
11. Thalassemia and related hemoglobinopathies.
Sarnaik SA
Indian J Pediatr; 2005 Apr; 72(4):319-24. PubMed ID: 15876761
[TBL] [Abstract][Full Text] [Related]
12. The management of thalassemia major.
Pearson HA; O'Brien RT
Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
[No Abstract] [Full Text] [Related]
13. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
Giardina PJ; Grady RW
Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
[TBL] [Abstract][Full Text] [Related]
14. Liver iron overload and liver fibrosis in thalassemia.
Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
[No Abstract] [Full Text] [Related]
15. Iron overload in thalassemia and sickle cell disease.
Taher A
Semin Hematol; 2005 Apr; 42(2 Suppl 1):S5-9. PubMed ID: 15846583
[No Abstract] [Full Text] [Related]
16. Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy.
Sheth S; Ruzal-Shapiro C; Hurlet-Jensen A; Piomelli S; Berdon WE
Pediatr Radiol; 1997 Dec; 27(12):926-8. PubMed ID: 9388284
[TBL] [Abstract][Full Text] [Related]
17. Growth plate injury of the long bones in treated beta-thalassemia.
Orzincolo C; Scutellari PN; Castaldi G
Skeletal Radiol; 1992; 21(1):39-44. PubMed ID: 1546335
[TBL] [Abstract][Full Text] [Related]
18. Fatal splenic sequestration crisis.
Benjamin JT; McMillan CW; Komp DM
Va Med; 1979 Sep; 106(9):679-80. PubMed ID: 484003
[No Abstract] [Full Text] [Related]
19. HIV infection and AIDS in thalassemia and sickle cell disease.
Girot R; Lefrere JJ
Haematologica; 1990; 75 Suppl 5():128-31. PubMed ID: 2086373
[No Abstract] [Full Text] [Related]
20. High-dose intravenous chelation therapy with deferoxamine.
Cohen A; Mizanin J; Schwartz E
Prog Clin Biol Res; 1989; 309():125-31. PubMed ID: 2780746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
